new version V2017

peripheral vascular diseases

     

TrialStudied treatmentControl treatmentpatientsROBResultNCT

antiplatelets drug

aspirin
CLIPS, 2007aspirinplacebo Low risk of bias Suggesting

antithrombotics

acenocoumarol
APIC, 1989acenocoumarolplacebo -
aspirin
Munich B, 1975aspirinplacebo -
Munich A, 1975aspirinplacebo -
Schoop, 1983aspirinplacebo -
Hess, 1985aspirinplacebo -
Lassila R, 1991aspirincontrôle -
BOA, 2000aspirin -
clopidogrel
CAPRIE (PAD subgroup), 1996clopidogrelaspirinSuggesting
AFFIRM ongoing clopidogrel -
dipyridamol
Schoop (2), 1983aspirin + dipyridamolplacebo -
Hess (2), 1985aspirin + dipyridamolplacebo -
VA study, 1986aspirin + dipyridamolplacebo -
ketanserine
Thulesius, 1987ketanserineplacebo -
Walden, 1991ketanserineplacebo -
PACK, 1996ketanserineplacebo -
picotamide
Coto, 1989picotamideplacebo -
ADEP, 1993picotamideplacebo -
Neirotti, 1994picotamideplacebo -
suloctidil
Adriaensen, 1976suloctidilplacebo -
Verhaeghe, 1981suloctidilplacebo -
Jones, 1982suloctidilplacebo -
Holm, 1984suloctidilplacebo -
ticlopidine
Hurlow, 1980ticlopidineplacebo -
Krause, 1980ticlopidineplacebo -
Katsumara, 1982ticlopidineplacebo -
Aukland, 1982ticlopidineplacebo -
Stiegler, 1984ticlopidineplacebo -
Cloarec, 1986ticlopidineplacebo -
Ellis, 1986ticlopidineplacebo -
Arcan, 1988ticlopidineplacebo -
Balsano, 1989ticlopidineplacebo -
STIMS, 1990ticlopidineplacebo -
EMATAP, 1993ticlopidineplacebo -
Becquemin, 1997ticlopidinecontrôle -
UFH
Tesi, 1989HNFplacebo -
Antonicelli, 1999HNFplacebo -
various
CRAMPS, 2000cloricromeneplacebo -
warfarin
Sarac, 1998warfarincontrôle -
Johnson, 2002warfarincontrôle -

cholesterol lowering intervention

atorvastatin
Mohler III, 2003atorvastatinplaceboPeripheral Arterial Disease Exploratory -
bezafibrate
LEADER trial, 2000bezafibrateplaceboPeripheral Arterial Disease Low risk of bias -
niacin
CLAS, 1987colestipol-niacinplaceboPeripheral Arterial Disease Exploratory -
probucol
PQRST, 1994probucolplaceboPeripheral Arterial Disease Exploratory -
simvastatin
HPS (sub group), 2002simvastatinplaceboPeripheral Arterial Disease Low risk of bias -
Mondillo, 2003simvastatinplaceboPeripheral Arterial Disease Exploratory -
Aronow , 2003simvastatinplaceboPeripheral Arterial Disease Exploratory -

Exercise Therapy

Exercise Therapy
Larsen OA, 1966Exercise TherapyControl -
Holm J, 1973Exercise TherapyControl -
Dahllof AG, 1974Exercise TherapyControl -
Hiatt WR, 1990Exercise TherapyControl -
Mannarino E, 1991Exercise TherapyControl -
Hiatt WR, 1994Exercise TherapyControl -
Tisi PV, 1997Exercise TherapyControl -
Gelin, 2001Exercise TherapyControl -
Gardner, 2001Exercise TherapyControl -
Fowler, 2002Exercise TherapyControl -
Lear PA ongoing Exercise TherapyControl -
Pockley G ongoing Exercise TherapyControl -
Stewart A ongoing Exercise TherapyControl -
McCloskey B ongoing Exercise TherapyControl -
Jayatunga AP ongoing Exercise TherapyControl -

vasodilators therapy

buflomedil
Diamantopoulos, 2001buflomédilplacebo -
LIMB, 2008buflomedilplacebo Low risk of bias Suggesting
cilostazol
Otsuka 21-95-201cilostazolplacebo -
Dawson, 1998cilostazolplacebo -
Money, 1998cilostazolplacebo -
Elam, 1998cilostazolplacebo -
Beebe, 1999cilostazolplacebo -
Dawson (cilostazol), 2000cilostazolplacebo -
Strandness, 2002cilostazolplacebo -
ginko biloba
Bauer, 1984ginko bilobaplacebo -
Peters, 1998ginko bilobaplacebo -
naftidrofuryl
Clyne, 1980naftidrofurylplacebo -
Meehan, 1982naftidrofuryl IVcontrol -
Negus, 1987naftidrofuryl IVprostacyclin -
Testart, 1994naftidrofuryl IVplacebo -
NIQOL germany, 1999Naftidrofurylplacebo -
NIQOL belgium, 2001naftidrofurylplacebo -
NCIS, 2001naftidrofurylplacebo -
D'Hooge D, 2001naftidrofuryl IVplacebo -
pentoxifylline
Porter, 1982pentoxifyllineplacebo -
Donaldson, 1984pentoxifyllineplacebo -
APIC, 1989pentoxifyllineplacebo -
Dawson (pentoxifylline), 2000pentoxifyllineplacebo -
Belcaro, 2002pentoxifyllineplacebo -